查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612552

生物银行市场：按产品类型、样本类型、储存类型、应用、最终用户 - 2025-2030 年全球预测

Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物银行市场价值为703.3亿美元，预计2024年将达到782.1亿美元，复合年增长率为11.71%，到2030年将达到1527.5亿美元。

生物银行是指用于研究和临床治疗的生物样本的收集、处理、储存和管理，在推进个人化医疗、基因组学和药物开发方面发挥重要作用。对生物银行的需求源于对高品质生物材料的日益增长的需求，以支持生物医学研究并在理解疾病和创新治疗方法实现突破。其应用涵盖多个领域，包括癌症研究、遗传疾病研究和流行病学。最终用户范围从学术研究机构到製药公司和医院。影响生物银行市场的关键成长要素包括慢性病的扩散、再生医学的进步以及研发活动资金的增加。精准医疗的日益普及使得这一点变得更加重要。然而，生物银行面临严格的监管要求、隐私和同意方面的道德问题以及样本储存和保存技术方面的挑战等限制。此外，生物库之间有限的资料存取和互通性也阻碍了进展。市场的新机会包括人工智慧和巨量资料分析的集成，以增强资料管理和解释。此外，移动和分散式生物银行方法的发展可以扩大样本的多样性和代表性。业务成长的创新部分包括创建用于样本处理的标准化通讯协定和用于安全资料共用的区块链应用程式。改善社区参与和培养社会信任对于克服道德挑战和鼓励参与生物银行倡议仍然很重要。生物银行市场的本质是竞争性和协作性的，生物技术公司、学术机构和医疗保健提供者之间有机会建立伙伴关係。进入这一领域的公司应专注于加强技术基础设施并形成策略联盟，以有效利用新技术。总体而言，生物银行处于变革性医疗保健解决方案的前沿，研究和创新对于释放其潜力至关重要。

主要市场统计
基准年[2023] 703.3亿美元
预测年份 [2024] 782.1亿美元
预测年份 [2030] 1527.5亿美元
复合年增长率（%） 11.71%

市场动态：揭示快速发展的生物银行市场的关键市场洞察

供需的动态交互作用正在改变生物银行市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 整个经济的慢性病负担日益加重，需要改善医疗基础设施
    • 增加私人和公共对药物研究的投资
    • 人们对再生医学和政府措施的认识不断增强
  • 市场限制因素
    • 由于生物样本库的分散性质而导致程序统一的相关问题
  • 市场机会
    • 持续研究以改善和标准化生物样本库的资料收集和分析
    • 人们越来越关註生物样本库的永续性和成像生物样本库的发展
  • 市场问题
    • 与生物银行相关的道德和法律问题

波特五力：驾驭生物银行市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解生物银行市场的外部影响

外部宏观环境因素在塑造生物银行市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解生物银行市场的竞争格局

对生物银行市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：生物银行市场供应商的绩效评估

FPNV定位矩阵是评估生物银行市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製生物银行市场的成功之路

生物银行市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病负担在整个经济中增加，需要改善卫生基础设施
      • 增加私人和公共对药物研究的投资
      • 人们对再生医学和政府措施的认识不断增强
    • 抑制因素
      • 与透过生物样本库分散化协调程序相关的问题
    • 机会
      • 正在进行的研究以改善和确保生物样本库资料收集和分析的标准化
      • 人们越来越关註生物样本库的永续性和成像生物样本库的发展
    • 任务
      • 与生物银行相关的道德和法律问题
  • 市场区隔分析
    • 产品：扩展软体整合以简化生物银行操作
    • 样本类型：在基因研究中增加核酸样本的使用
    • 储存类型：由于效率和可扩充性，自动化储存系统越来越受青睐。
    • 最终用户：扩大生物样本库在製药领域的药物开发
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生物银行市场：副产品

  • 介绍
  • 消耗品
  • 设备与设备
  • 服务
  • 软体

第七章生物银行市场：依样本类型

  • 介绍
  • 体液
  • 血液製品
  • 细胞株
  • 人体组织
  • 核酸

第八章生物银行市场：依储存类型

  • 介绍
  • 自动的
  • 手动的

第九章生物银行市场：依应用分类

  • 介绍
  • 临床研究
  • 生命科学研究
  • 再生医学

第 10 章生物银行市场：按最终用户分类

  • 介绍
  • 学术研究所
  • 医院
  • 製药/生物技术

第十一章美洲生物银行市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太生物银行市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的生物银行市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新的生物银行伙伴关係关係保护美国濒危物种的遗传多样性
    • Crown Bioscience 收购 Indivumed 的服务业务并支持生物样本库
    • CNIO生物银行从欧盟获得80万欧元
  • 战略分析和建议

公司名单

  • AMS BIoTechnology（Europe）Limited
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Sciences
  • Bay Biosciences LLC
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L'AIR LIQUIDE SA
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBIoTech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • Merck KgaA
  • Micronic Holding BV
  • PHC Holdings Corporation
  • Promega Corporation
  • ProteoGenex
  • QIAGEN NV
  • Sopachem NV/SA
  • SPT Labtech Ltd.
  • STEMCELL Technologies Inc.
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited
  • US Biolab Corporation, Inc.
Product Code: MRR-961BA04A2DC3

The Biobanking Market was valued at USD 70.33 billion in 2023, expected to reach USD 78.21 billion in 2024, and is projected to grow at a CAGR of 11.71%, to USD 152.75 billion by 2030.

Biobanking refers to the collection, processing, storage, and management of biological samples for research and clinical care, playing an essential role in advancing personalized medicine, genomics, and drug development. The necessity of biobanking arises from the growing need for high-quality biomaterials to support biomedical research, enabling breakthroughs in disease understanding and therapeutic innovation. Its applications span across various domains, including cancer research, genetic disorder studies, and epidemiology. End-users range from academic and research institutions to pharmaceutical companies and hospitals. Key growth factors influencing the biobanking market include the surge in chronic disease prevalence, advancements in regenerative medicine, and increased funding for R&D activities. The expanding adoption of precision medicine further amplifies its importance. However, biobanking faces limitations such as stringent regulatory requirements, ethical concerns regarding privacy and consent, and challenges in sample storage and preservation technologies. Moreover, limited data access and interoperability between biobanks can impede progress. Emerging opportunities in the market include the integration of artificial intelligence and big data analytics to enhance data management and interpretation. Additionally, the development of mobile and decentralized biobanking approaches can broaden sample diversity and representation. Innovative areas for business growth include the creation of standardized protocols for sample handling and blockchain applications for secure data sharing. Improving community engagement and fostering public trust remain critical to overcoming ethical challenges and boosting participation in biobanking initiatives. The nature of the biobanking market is competitive yet collaborative, with opportunities for partnerships among biotechnology firms, academic institutions, and healthcare providers. Companies venturing into this space should focus on enhancing their technological infrastructure and forming strategic alliances to harness emerging technologies effectively. Overall, biobanking stands at the forefront of transformative healthcare solutions, with research and innovation being pivotal to unlocking its potential.

KEY MARKET STATISTICS
Base Year [2023] USD 70.33 billion
Estimated Year [2024] USD 78.21 billion
Forecast Year [2030] USD 152.75 billion
CAGR (%) 11.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanking Market

The Biobanking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
    • Growing private and public investments in pharmaceutical research
    • Rising awareness and government initiatives in regenerative medicine
  • Market Restraints
    • Problems associated with procedure harmonization due to decentralized nature of biobanks
  • Market Opportunities
    • Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
    • Emerging focus on biobank sustainability and development of imaging biobanks
  • Market Challenges
    • Ethical and legal concerns associated with biobanking

Porter's Five Forces: A Strategic Tool for Navigating the Biobanking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanking Market

A detailed market share analysis in the Biobanking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanking Market

A strategic analysis of the Biobanking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Market Segmentation & Coverage

This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software.
  • Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
  • Based on Storage Type, market is studied across Automated and Manual.
  • Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
      • 5.1.1.2. Growing private and public investments in pharmaceutical research
      • 5.1.1.3. Rising awareness and government initiatives in regenerative medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
      • 5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns associated with biobanking
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding software integration to facilitate the biobanking operations
    • 5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
    • 5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
    • 5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biobanking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment & Instruments
  • 6.4. Services
  • 6.5. Software

7. Biobanking Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Fluids
  • 7.3. Blood Products
  • 7.4. Cell Lines
  • 7.5. Human Tissues
  • 7.6. Nucleic Acids

8. Biobanking Market, by Storage Type

  • 8.1. Introduction
  • 8.2. Automated
  • 8.3. Manual

9. Biobanking Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Research
  • 9.3. Life Science Research
  • 9.4. Regenerative Medicine

10. Biobanking Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Biobanking Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biobanking Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biobanking Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
    • 14.3.2. Crown Bioscience to Acquire Indivumed's Service Business and Supporting Biobank
    • 14.3.3. CNIO biobank receives EUR 800,000 from the EU
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AMS Biotechnology (Europe) Limited
  • 2. ASKION GmbH
  • 3. Avantor, Inc.
  • 4. Azenta Life Sciences
  • 5. Bay Biosciences LLC
  • 6. Becton, Dickinson and Company
  • 7. BioIVT LLC
  • 8. BioKryo by L'AIR LIQUIDE S.A.
  • 9. BocaBio
  • 10. Charles River Laboratories International, Inc.
  • 11. Cryoport Systems, LLC
  • 12. CTIBiotech
  • 13. Cureline, Inc.
  • 14. Firalis Group
  • 15. Greiner AG
  • 16. Hamilton Company
  • 17. Merck KgaA
  • 18. Micronic Holding B.V.
  • 19. PHC Holdings Corporation
  • 20. Promega Corporation
  • 21. ProteoGenex
  • 22. QIAGEN N.V.
  • 23. Sopachem NV/SA
  • 24. SPT Labtech Ltd.
  • 25. STEMCELL Technologies Inc.
  • 26. Taylor-Wharton
  • 27. Tecan Trading AG
  • 28. Thermo Fisher Scientific Inc.
  • 29. UK Biobank Limited
  • 30. US Biolab Corporation, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOBANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOBANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023